Decreased survival in normal karyotype AML with single-nucleotide polymorphisms in genes encoding the AraC metabolizing enzymes cytidine deaminase and 5′-nucleotidase

Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogenetics

(2011) Hady Ghanem et al.   AMERICAN JOURNAL OF HEMATOLOGY

Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management

(2011) Elihu H. Estey   AMERICAN JOURNAL OF HEMATOLOGY

Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5′-nucleotidase II expression ratio in primary acute myeloid leukemia cells

(2009) Takahiro Yamauchi et al.   BIOCHEMICAL PHARMACOLOGY

The favorable impact of CEBPA mutations in patients with acute myeloid leukemia is only observed in the absence of associated cytogenetic abnormalities and FLT3 internal duplication

(2009) A. Renneville et al.   BLOOD

Clinical pharmacology and pharmacogenetics of gemcitabine

(2009) Andrea Wong et al.   DRUG METABOLISM REVIEWS

Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study

(2009) Anders Wahlin et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

SNP analyses in cytarabine metabolizing enzymes in AML patients and their impact on treatment response and patient survival: identification of CDA SNP C-451T as an independent prognostic parameter for survival

(2009) U Mahlknecht et al.   LEUKEMIA

Genetic factors influencing cytarabine therapy

(2009) Jatinder K Lamba   PHARMACOGENOMICS

AID-induced decrease in topoisomerase 1 induces DNA structural alteration and DNA cleavage for class switch recombination

(2009) Maki Kobayashi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2′-deoxycytidine

(2008) Maryse Lemaire et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Differential Allelic Expression in Leukoblast from Patients with Acute Myeloid Leukemia Suggests Genetic Regulation of CDA, DCK, NT5C2, NT5C3, and TP53

(2008) L. P. Jordheim et al.   DRUG METABOLISM AND DISPOSITION

Twenty Novel Genetic Variations and Haplotype Structures of the DCK Gene Encoding Human Deoxycytidine Kinase (dCK)

(2008) Su-Ryang Kim et al.   Drug Metabolism and Pharmacokinetics

Correlation Between Cytidine Deaminase Genotype and Gemcitabine Deamination in Blood Samples

(2008) E. Giovannetti et al.   NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS

ABCB1 G1199A Polymorphism and Ovarian Cancer Response to Paclitaxel

(2007) Henrik Gréen et al.   JOURNAL OF PHARMACEUTICAL SCIENCES